tiprankstipranks
Advertisement
Advertisement
Analyst Maintains Hold on Edwards with Neutral Risk-Reward and Reiterated $85 Price Target Amid Pending TAVR Catalysts
PremiumRatingsAnalyst Maintains Hold on Edwards with Neutral Risk-Reward and Reiterated $85 Price Target Amid Pending TAVR Catalysts
7d ago
SpaceX initiated, PayPal upgraded: Wall Street’s top analyst calls
Premium
The Fly
SpaceX initiated, PayPal upgraded: Wall Street’s top analyst calls
7d ago
Edwards Lifesciences price target raised to $105 from $100 at JPMorgan
Premium
The Fly
Edwards Lifesciences price target raised to $105 from $100 at JPMorgan
7d ago
Edwards Lifesciences reports Q2 EPS 78c, consensus 74c
PremiumThe FlyEdwards Lifesciences reports Q2 EPS 78c, consensus 74c
8d ago
Edwards Lifesciences sees Q3 EPS 71c-77c, consensus 75c
Premium
The Fly
Edwards Lifesciences sees Q3 EPS 71c-77c, consensus 75c
8d ago
Edwards Lifesciences affirms FY26 EPS view of $2.95-$3.05, consensus $3.01
Premium
The Fly
Edwards Lifesciences affirms FY26 EPS view of $2.95-$3.05, consensus $3.01
8d ago
EW Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-EarningsEW Earnings Report this Week: Is It a Buy, Ahead of Earnings?
10d ago
Edwards Lifesciences Expands Pediatric Heart Portfolio With Autus Valve Access Study
Premium
Company Announcements
Edwards Lifesciences Expands Pediatric Heart Portfolio With Autus Valve Access Study
14d ago
Edwards Lifesciences Advances Real-World Study on New Aortic Valve Conduit
Premium
Company Announcements
Edwards Lifesciences Advances Real-World Study on New Aortic Valve Conduit
14d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100